TASO-001 in Combination With Recombinant Interleukin-2(Aldesleukin) in Advanced or Metastatic Solid Tumor
Clinical trial NCT04862767 · COMPLETED
Trial details
- NCT number
- NCT04862767
- Sponsor
- Autotelicbio
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-03-09
- Primary completion
- 2023-08-21
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.